Successful long-term treatment of refractory Cushing's disease with high-dose mifepristone (RU 486)

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 8, 2001, Pages 3568-3573

  Chu, James W ^a   Matthias, Dwight F ^a   Belanoff, Joseph ^a   Schatzberg, Alan ^a   Hoffman, Andrew R ^a   Feldman, David ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; MIFEPRISTONE; MINERALOCORTICOID RECEPTOR; SPIRONOLACTONE;

ADULT; ARTICLE; CARDIOMYOPATHY; CASE REPORT; CUSHING DISEASE; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG EFFICACY; HEART FAILURE; HORMONE ACTION; HUMAN; HYPOKALEMIA; HYPOPHYSIS ADENOMA; LONG TERM CARE; MALE; METABOLIC DISORDER; PRIORITY JOURNAL; PSYCHOSIS; TREATMENT OUTCOME; TREATMENT PLANNING;

ADRENOCORTICOTROPIC HORMONE; AFRICAN AMERICANS; BONE DENSITY; BRAIN; CALIFORNIA; CHOLESTEROL; CUSHING SYNDROME; DEPRESSIVE DISORDER; HEART FAILURE, CONGESTIVE; HEMOGLOBIN A, GLYCOSYLATED; HORMONE ANTAGONISTS; HUMANS; HYDROCORTISONE; MAGNETIC RESONANCE IMAGING; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; MIFEPRISTONE; OSTEOCALCIN; VENTRICULAR FUNCTION, LEFT;

EID: 0034880195     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.86.8.3568     Document Type: Article

References (19)

1. Diseases of the adrenal cortex
2. Medical therapy for Cushing's disease
3. Mifepristone (RU 486) - A modulator of progestin and glucocorticoid action
4. Newer diagnostic techniques and problems in Cushing's disease
5. Ketoconazole and other imidazole derivatives as inhibitors of steroidogenesis
6. Rapid reversal of psychotic major depression using mifepristone
7. Pituitary-adrenal response to the antiglucocorticoid action of RU 486 in Cushing's syndrome
8. Cushing's disease in a patient with a 'nonfunctioning' pituitary tumor. Spontaneous development and remission
9. Mifepristone. Auxiliary therapeutic use in cancer and related disorders
10. Successful treatment of Cushing's syndrome with the glucocorticoid antagonist RU 486
11. Mifepristone: Treatment of Cushing's syndrome
12. Mineralocorticoid action: Target tissue specificity is enzyme, not receptor, mediated
13. 11β-hydroxysteroid dehydrogenase activity in Cushing's syndrome: Explaining the mineralocorticoid excess state of the ectopic adrenocorticotropin syndrome
14. Cardiac characteristics and postoperative courses in Cushing's syndrome
15. Left ventricular structural characteristics in Cushing's syndrome
16. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system
17. Aldosterone and antialdosterone therapy in congestive heart failure
18. The effect of spironolactone on morbidity and mortality in patients with severe heart failure
19. The longitudinal course of psychopathology in Cushing's syndrome after correction of hypercortisolism